• court saves the day
    court saves the day
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • [OC] Workplace accident
    [OC] Workplace accident
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • Somewhere between teething and emotional breakup anthems.
    Somewhere between teething and emotional breakup anthems.
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • 【ガンダムSEED freedom】
    *マリュー ラミアス*

    Photo カサさん(@ambitious530 )

    #めぐcos #コスプレ #アコスタ羽田エアポートガーデン
    【ガンダムSEED freedom】 *マリュー ラミアス* Photo カサさん(@ambitious530 ) #めぐcos #コスプレ #アコスタ羽田エアポートガーデン
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • 𝐘𝐞̂𝐮 𝐞𝐦 đ𝐢 𝐞𝐦 𝐜𝐡𝐨 𝐜𝐡𝐨̛𝐦 𝐦𝐚́...
    𝐘𝐞̂𝐮 𝐞𝐦 đ𝐢 𝐞𝐦 𝐜𝐡𝐨 𝐜𝐡𝐨̛𝐦 𝐦𝐚́...
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • Ô tô con biến dạng hoàn toàn sau va chạm liên hoàn trên Quốc lộ 4D đoạn qua thị xã Sa Pa sáng 8/6, giao thông trên tuyến đèo huyết mạch này cũng ùn tắc kéo dài.

    Theo thông tin ban đầu, có một số người bị thương và được đưa đi cấp cứu.

    Theo: VTC News / Thủy Nguyễn
    Ô tô con biến dạng hoàn toàn sau va chạm liên hoàn trên Quốc lộ 4D đoạn qua thị xã Sa Pa sáng 8/6, giao thông trên tuyến đèo huyết mạch này cũng ùn tắc kéo dài. Theo thông tin ban đầu, có một số người bị thương và được đưa đi cấp cứu. Theo: VTC News / Thủy Nguyễn
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • Tuberculosis has plagued humanity for centuries, killing more people each year than nearly any other infectious disease. But scientists may have finally turned the tide. A new mRNA vaccine, dubbed mRNACV2, has demonstrated strong effectiveness in preclinical trials—triggering a powerful immune response in mice and dramatically reducing the bacterial load in their lungs. This represents a major leap beyond the current BCG vaccine, which offers limited protection and hasn't changed much since its introduction in 1921.

    What makes this breakthrough especially significant is the use of mRNA technology—the same approach that powered COVID-19 vaccines. This marks the first time mRNA has shown such promise against a bacterial infection, not just viruses. With human trials now on the horizon, the medical community is hopeful that this could lead to a durable, global solution for TB—a disease that still kills over 1 million people annually despite being preventable and treatable.

    #mRNAVaccine #TBCure #MedicalBreakthrough #InfectiousDiseases
    #PublicHealthRevolution
    Tuberculosis has plagued humanity for centuries, killing more people each year than nearly any other infectious disease. But scientists may have finally turned the tide. A new mRNA vaccine, dubbed mRNACV2, has demonstrated strong effectiveness in preclinical trials—triggering a powerful immune response in mice and dramatically reducing the bacterial load in their lungs. This represents a major leap beyond the current BCG vaccine, which offers limited protection and hasn't changed much since its introduction in 1921. What makes this breakthrough especially significant is the use of mRNA technology—the same approach that powered COVID-19 vaccines. This marks the first time mRNA has shown such promise against a bacterial infection, not just viruses. With human trials now on the horizon, the medical community is hopeful that this could lead to a durable, global solution for TB—a disease that still kills over 1 million people annually despite being preventable and treatable. #mRNAVaccine #TBCure #MedicalBreakthrough #InfectiousDiseases #PublicHealthRevolution
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • Who would've thought..
    Who would've thought..
    0 Comentários 0 Compartilhamentos 22K Visualizações
  • BJ NomNom's personal experience
    BJ NomNom's personal experience
    0 Comentários 0 Compartilhamentos 22K Visualizações